47 related articles for article (PubMed ID: 35546442)
21. An exploration in pitfalls in interpreting SDHB immunohistochemistry.
Ding CC; Chan S; Mak J; Umetsu SE; Simko JP; Ruiz-Cordero R; Saunders T; Chan E
Histopathology; 2022 Aug; 81(2):264-269. PubMed ID: 35546442
[TBL] [Abstract][Full Text] [Related]
22. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
23. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
24. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
25. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
[TBL] [Abstract][Full Text] [Related]
26.
Schipani A; Nannini M; Astolfi A; Pantaleo MA
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980917
[TBL] [Abstract][Full Text] [Related]
27. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract][Full Text] [Related]
28. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract][Full Text] [Related]
29. Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency.
Pitsava G; Settas N; Faucz FR; Stratakis CA
Front Endocrinol (Lausanne); 2021; 12():680609. PubMed ID: 34012423
[TBL] [Abstract][Full Text] [Related]
30. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
[TBL] [Abstract][Full Text] [Related]
31. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours.
Loughrey PB; Roncaroli F; Healy E; Weir P; Basetti M; Casey RT; Hunter SJ; Korbonits M
Endocr Relat Cancer; 2022 Oct; 29(10):R157-R172. PubMed ID: 35938916
[TBL] [Abstract][Full Text] [Related]
32. Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers.
Wong MY; Andrews KA; Challis BG; Park SM; Acerini CL; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2019 Apr; 90(4):499-505. PubMed ID: 30589099
[TBL] [Abstract][Full Text] [Related]
33. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.
Pasini B; Stratakis CA
J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823
[TBL] [Abstract][Full Text] [Related]
34. Paraganglioma of the Vagina Associated With Germline SDHB Mutation: Report of a Case With Review of the Literature.
Wong RW; Liu APY; Choi CKM; Chan AOK
Int J Gynecol Pathol; 2020 Nov; 39(6):599-604. PubMed ID: 31851064
[TBL] [Abstract][Full Text] [Related]
35. Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.
Settas N; Faucz FR; Stratakis CA
Mol Cell Endocrinol; 2018 Jul; 469():107-111. PubMed ID: 28739378
[TBL] [Abstract][Full Text] [Related]
36. Gene of the month: SDH.
Aldera AP; Govender D
J Clin Pathol; 2018 Feb; 71(2):95-97. PubMed ID: 29070651
[TBL] [Abstract][Full Text] [Related]
37. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
Baysal BE; Maher ER
Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
[TBL] [Abstract][Full Text] [Related]
38. Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.
Evenepoel L; Papathomas TG; Krol N; Korpershoek E; de Krijger RR; Persu A; Dinjens WN
Genet Med; 2015 Aug; 17(8):610-20. PubMed ID: 25394176
[TBL] [Abstract][Full Text] [Related]
39. SDH-deficient renal cell carcinoma: a clinicopathological analysis highlighting the role of genetic counselling.
Wilczek Y; Sachdeva A; Turner H; Veeratterapillay R
Ann R Coll Surg Engl; 2021 Jan; 103(1):e20-e22. PubMed ID: 32969237
[TBL] [Abstract][Full Text] [Related]
40. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers.
Amar L; Pacak K; Steichen O; Akker SA; Aylwin SJB; Baudin E; Buffet A; Burnichon N; Clifton-Bligh RJ; Dahia PLM; Fassnacht M; Grossman AB; Herman P; Hicks RJ; Januszewicz A; Jimenez C; Kunst HPM; Lewis D; Mannelli M; Naruse M; Robledo M; Taïeb D; Taylor DR; Timmers HJLM; Treglia G; Tufton N; Young WF; Lenders JWM; Gimenez-Roqueplo AP; Lussey-Lepoutre C
Nat Rev Endocrinol; 2021 Jul; 17(7):435-444. PubMed ID: 34021277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
